SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-167891
Filing Date
2023-06-15
Accepted
2023-06-15 16:06:58
Documents
13
Period of Report
2023-06-10
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d515127d8k.htm   iXBRL 8-K 39957
2 EX-3.1 d515127dex31.htm EX-3.1 182131
  Complete submission text file 0001193125-23-167891.txt   388770

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alec-20230610.xsd EX-101.SCH 2839
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alec-20230610_lab.xml EX-101.LAB 18740
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alec-20230610_pre.xml EX-101.PRE 11700
7 EXTRACTED XBRL INSTANCE DOCUMENT d515127d8k_htm.xml XML 3535
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 822933343 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 231017382
SIC: 2836 Biological Products, (No Diagnostic Substances)